{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:30:13Z","timestamp":1791322213737,"version":"4.3.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,8,13]],"date-time":"2007-08-13T00:00:00Z","timestamp":1186963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,8,13]],"date-time":"2007-08-13T00:00:00Z","timestamp":1186963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2008,2,14]]},"DOI":"10.1038\/sj.onc.1210721","type":"journal-article","created":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T11:13:38Z","timestamp":1187090018000},"page":"1055-1062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Defective TGF-\u03b2 signaling sensitizes human cancer cells to rapamycin"],"prefix":"10.1038","volume":"27","author":[{"given":"N","family":"Gadir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D N","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,13]]},"reference":[{"key":"BF1210721_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ijc.11487","volume":"107","author":"R Baserga","year":"2003","unstructured":"Baserga R, Peruzzi F, Reiss K . (2003). The IGF-1 receptor in cancer biology. Int J Cancer 107: 873\u2013877.","journal-title":"Int J Cancer"},{"key":"BF1210721_CR2","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1242\/jcs.115.14.2829","volume":"115","author":"F Borel","year":"2002","unstructured":"Borel F, Lacroix FB, Margolis RL . (2002). Prolonged arrest of mammalian cells at the G1\/S boundary results in permanent S-phase stasis. J Cell Sci 115: 2829\u20132838.","journal-title":"J Cell Sci"},{"key":"BF1210721_CR3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1073\/pnas.98.3.992","volume":"98","author":"CR Chen","year":"2001","unstructured":"Chen CR, Kang Y, Massague J . (2001). Defective repression of c-Myc in breast cancer cells: a loss at the core of the transforming growth factor-\u03b2 growth arrest program. Proc Natl Acad Sci USA 98: 992\u2013999.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210721_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/sj.onc.1208099","volume":"24","author":"Y Chen","year":"2005","unstructured":"Chen Y, Rodrik V, Foster DA . (2005). Alternative phospholipase D\/mTOR survival signal in human breast cancer cells. Oncogene 24: 672\u2013679.","journal-title":"Oncogene"},{"key":"BF1210721_CR5","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1038\/sj.onc.1206565","volume":"22","author":"Y Chen","year":"2003","unstructured":"Chen Y, Zheng Y, Foster DA . (2003). Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene 22: 3937\u20133942.","journal-title":"Oncogene"},{"key":"BF1210721_CR6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/sj.onc.1206128","volume":"22","author":"SP Fink","year":"2004","unstructured":"Fink SP, Mikkola D, Willson JK, Maekowitz S . (2004). TGF-\u03b2-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines. Oncogene 22: 1317\u20131323.","journal-title":"Oncogene"},{"key":"BF1210721_CR7","first-page":"256","volume":"61","author":"SP Fink","year":"2001","unstructured":"Fink SP, Swinler SE, Lutterbaugh JD, Massague J, Thiagalingam S, Kinzler KW et al. (2001). Transforming growth factor-\u03b2-induced growth inhibition in a Smad4 mutant colon adenoma cell line. Cancer Res 61: 256\u2013260.","journal-title":"Cancer Res"},{"key":"BF1210721_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1586\/14737140.4.4.691","volume":"4","author":"DA Foster","year":"2004","unstructured":"Foster DA . (2004). Targeting mTOR-mediated survival signals in anticancer therapeutic strategies. Expert Rev Anticancer Ther 4: 691\u2013701.","journal-title":"Expert Rev Anticancer Ther"},{"key":"BF1210721_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/157436206778226941","volume":"1","author":"DA Foster","year":"2006","unstructured":"Foster DA . (2006). Phospholipase D survival signals as a therapeutic target in cancer. Curr Signal Transduct Ther 1: 295\u2013303.","journal-title":"Curr Signal Transduct Ther"},{"key":"BF1210721_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/0008-5472.CAN-06-3016","volume":"67","author":"DA Foster","year":"2007","unstructured":"Foster DA . (2007). Regulation of mTOR by phosphatidic acid? Cancer Res 67: 1\u20134.","journal-title":"Cancer Res"},{"key":"BF1210721_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.molmed.2005.06.007","volume":"11","author":"DA Guertin","year":"2005","unstructured":"Guertin DA, Sabatini DM . (2005). An expanding role for mTOR in cancer. Trends Mol Med 11: 353\u2013361.","journal-title":"Trends Mol Med"},{"key":"BF1210721_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA . (2000). The hallmarks of cancer. Cell 100: 57\u201370.","journal-title":"Cell"},{"key":"BF1210721_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0959-437X(01)00263-5","volume":"12","author":"A Ho","year":"2002","unstructured":"Ho A, Dowdy SF . (2002). Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes. Curr Opin Genet Dev 12: 47\u201352.","journal-title":"Curr Opin Genet Dev"},{"key":"BF1210721_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1124\/mol.62.1.65","volume":"62","author":"GJ Inman","year":"2002","unstructured":"Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD et al. (2002). SB-431542 is a potent and specific inhibitor of transforming growth factor-\u03b2 superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65\u201374.","journal-title":"Mol Pharmacol"},{"key":"BF1210721_CR15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1096\/fj.03-0979rev","volume":"18","author":"D Jackson","year":"2004","unstructured":"Jackson D, Foster DA . (2004). The enigmatic protein kinase C\u03b4: complex roles in cell proliferation and survival. FASEB J 18: 627\u2013636.","journal-title":"FASEB J"},{"key":"BF1210721_CR16","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1038\/sj.onc.1208465","volume":"24","author":"D Jackson","year":"2005","unstructured":"Jackson D, Zheng Y, Lyo D, Shen Y, Nakayama K, Humphries M et al. (2005). Suppression of cell migration by protein kinase C\u03b4. Oncogene 24: 3067\u20133072.","journal-title":"Oncogene"},{"key":"BF1210721_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1535-6108(02)00093-4","volume":"2","author":"EM Jaffe","year":"2002","unstructured":"Jaffe EM, Hruban RH, Canto M, Kern SE . (2002). Focus on pancreas cancer. Cancer Cell 2: 25\u201328.","journal-title":"Cancer Cell"},{"key":"BF1210721_CR18","first-page":"1151","volume":"6","author":"E Kalkhoven","year":"1995","unstructured":"Kalkhoven E, Roelen BA, de Winter JP, Mummery CL, van den Eijnden-van Raaij AJ, van der Saag PT et al. (1995). Resistance to transforming growth factor \u03b2 and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ 6: 1151\u20131161.","journal-title":"Cell Growth Differ"},{"key":"BF1210721_CR19","doi-asserted-by":"publisher","first-page":"8184","DOI":"10.1128\/MCB.22.23.8184-8198.2002","volume":"22","author":"BK Law","year":"2002","unstructured":"Law BK, Chytil A, Dumont N, Hamilton EG, Waltner-Law ME, Aakre ME et al. (2002). Rapamycin potentiates transforming growth factor \u03b2-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells. Mol Cell Biol 22: 8184\u20138198.","journal-title":"Mol Cell Biol"},{"key":"BF1210721_CR20","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1128\/MCB.17.6.3418","volume":"17","author":"Z Lu","year":"1997","unstructured":"Lu Z, Hornia A, Jiang YW, Frankel P, Zang Q, Ohno S et al. (1997). Tumor-promotion by depleting cells of protein kinase C\u03b4. Mol Cell Biol 17: 3418\u20133428.","journal-title":"Mol Cell Biol"},{"key":"BF1210721_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","volume":"4","author":"J Luo","year":"2003","unstructured":"Luo J, Manning BD, Cantley LC . (2003). Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4: 257\u2013262.","journal-title":"Cancer Cell"},{"key":"BF1210721_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0006-291X(03)01066-0","volume":"306","author":"M Miyaki","year":"2003","unstructured":"Miyaki M, Kuroki T . (2003). Role of Smad4 (DPC4) inactivation in human cancer. Biochem Biophys Res Commun 306: 799\u2013804.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF1210721_CR23","doi-asserted-by":"publisher","first-page":"10314","DOI":"10.1073\/pnas.171076798","volume":"98","author":"MS Neshat","year":"2001","unstructured":"Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R et al. (2001). Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR. Proc Natl Acad Sci USA 98: 10314\u201310319.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210721_CR24","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1074\/jbc.M107984200","volume":"277","author":"PR Perillan","year":"2002","unstructured":"Perillan PR, Chen M, Potts EA, Simard JM . (2002). Transforming growth factor\u03b2 1 regulates Kir2.3 inward rectifier K+ channels via phospholipase C and protein kinase C-\u03b4 in reactive astrocytes from adult rat brain. J Biol Chem 277: 1974\u20131980.","journal-title":"J Biol Chem"},{"key":"BF1210721_CR25","doi-asserted-by":"publisher","first-page":"10320","DOI":"10.1073\/pnas.171060098","volume":"98","author":"K Podsypanina","year":"2001","unstructured":"Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J et al. (2001). An inhibitor of mTOR reduces neoplasia and normalizes p70\/S6 kinase activity in Pten+\/\u2212 mice. Proc Natl Acad Sci USA 98: 10320\u201310325.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1210721_CR26","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.ejca.2005.04.039","volume":"41","author":"S Popat","year":"2005","unstructured":"Popat S, Houlston RS . (2005). A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer 41: 2060\u20132070.","journal-title":"Eur J Cancer"},{"key":"BF1210721_CR27","doi-asserted-by":"publisher","first-page":"F413","DOI":"10.1152\/ajprenal.00082.2003","volume":"285","author":"CE Runyan","year":"2003","unstructured":"Runyan CE, Schnaper HW, Poncelet AC . (2003). Smad3 and PKC\u03b4 mediate TGF-\u03b21-induced collagen I expression in human mesangial cells. Am J Physiol Renal Physiol 285: F413\u2013F422.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BF1210721_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1535-6108(03)00275-7","volume":"4","author":"CL Sawyers","year":"2003","unstructured":"Sawyers CL . (2003). Will mTOR inhibitors make it as cancer drugs? Cancer Cell 4: 343\u2013348.","journal-title":"Cancer Cell"},{"key":"BF1210721_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","volume":"103","author":"T Schmelzle","year":"2000","unstructured":"Schmelzle T, Hall MN . (2000). TOR, a central controller of cell growth. Cell 103: 253\u2013262.","journal-title":"Cell"},{"key":"BF1210721_CR30","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nrc1208","volume":"3","author":"PM Siegel","year":"2003","unstructured":"Siegel PM, Massague J . (2003). Cytostatic and apoptotic actions of TGF-\u03b2 in homeostasis and cancer. Nat Rev Cancer 3: 807\u2013821.","journal-title":"Nat Rev Cancer"},{"key":"BF1210721_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/sj.emboj.7600917","volume":"25","author":"K Song","year":"2006","unstructured":"Song K, Wang H., Krebs TL, Danielpour D . (2006). Novel roles of Akt and mTOR in suppressing TGF-\u03b2\/ALK5-mediated Smad3 activation. EMBO J 25: 58\u201369.","journal-title":"EMBO J"},{"key":"BF1210721_CR32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00240-002-0282-1","volume":"30","author":"HG van der Poel","year":"2003","unstructured":"van der Poel HG, Hanrahan C, Zhong H, Simons JW . (2003). Rapamycin induces Smad activity in prostate cancer cell lines. Urol Res 30: 380\u2013386.","journal-title":"Urol Res"},{"key":"BF1210721_CR33","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/01.ju.0000138829.97838.19","volume":"172","author":"HG van der Poel","year":"2004","unstructured":"van der Poel HG . (2004). Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-\u03b21 in prostate cancer cells. J Urol 172: 1333\u20131337.","journal-title":"J Urol"},{"key":"BF1210721_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0006-291X(03)00229-8","volume":"302","author":"M Zhong","year":"2003","unstructured":"Zhong M, Shen Y, Zheng Y, Joseph T, Jackson D, Beychenok S et al. (2003). Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells. Biochem Biophys Res Commun 302: 615\u2013619.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1210721.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210721","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1210721.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T09:43:23Z","timestamp":1647942203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1210721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,13]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,2,14]]}},"alternative-id":["BF1210721"],"URL":"https:\/\/doi.org\/10.1038\/sj.onc.1210721","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,13]]},"assertion":[{"value":"26 April 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}